Press release
Global Psoriasis Drugs Market is predicted to progress at a CAGR of 6.5% to reach US$ 21.48 Bn by 2031
Among these treatments, psoriasis drugs have become increasingly popular as they work to reduce inflammation and slow down the production of skin cells. For example, some psoriasis medications block certain enzymes or hormones involved in the immune response which helps to prevent further damage from occurring. Additionally, drugs such as cyclosporine can be used to decrease inflammation while phototherapy can help reduce itching, redness and irritation.
Request For Free Sample Report of "Psoriasis Drugs Market"@ https://www.persistencemarketresearch.com/samples/25102
Psoriasis is a chronic inflammatory skin disease that occurs due to genetic disposition and environmental factors. Psoriasis is a systemic disease associated with psychological, metabolic, arthritic, and cardiovascular comorbidities. On an average, psoriasis affects around 2 - 3% of the population globally.
Plaque psoriasis, being the number one and most common indication, held nearly 85% share of the US$ 11.37 Bn psoriasis drugs market in 2021, with the market estimated to expand at a CAGR of nearly 6.5% over the next ten years.
An array of agents exist for the symptomatic treatment of psoriasis. Patients with mild-to-moderate psoriasis typically receive topical treatments that modulate gene transcription, promote keratinocyte differentiation, and inhibit cell proliferation.
A number of innovative and advanced therapies for the treatment and management of psoriasis are under development, many of which have novel targets and mechanisms of action. Psoriasis is linked with a number of medical conditions inclusive of psoriatic arthritis, depression, and cardio metabolic syndrome. The most commonly occurring form of psoriasis is chronic plaque.
Key Takeaways from Market Study
Topical products are expected to continue holding over one-third market value share through 2031, primarily because of clinically approved topical ointments, foams, and creams available for the management of inflammation and rash due to psoriasis.
Efficiency of corticosteroids for skin irritability and inflammation makes corticosteroid the leading segment with over 34% of revenue share in 2021.
Easy availability of psoriasis drugs in hospital pharmacies and large distribution networks of hospital chains make it the largest segment, with more than 39% market share.
Plaque psoriasis is the most commonly occurring autoimmune disease, accounting for a revenue share of around 85% in 2021.
Presence of a large number of manufacturers, rising public awareness, and easy availability of psoriasis drugs and treatment options make North America the leading regional market with over 27% market share in 2021.
"Growing adoption of combination therapy and favourable reimbursement support for psoriasis to drive market growth," says an analyst of Persistence Market Research.
Buy Full Report Now @ https://www.persistencemarketresearch.com/checkout/25102
Market Competition
Companies such as Amgen and Sun Pharma have been strongly working toward the development of an extensive clinical pipeline and manufacturing of new product lines for the treatment of psoriasis.
In December 2021, Amgen announced positive top-line results from the Otezla® (apremilast) Phase 3 DISCREET study in moderate to severe genital psoriasis.
In September 2020, Sun Pharma announced the launch of ILUMYA® (tildrakizumab) for the treatment of plaque psoriasis, in Japan.
Similarly, other psoriasis drug manufacturers are also trying to maintain and strengthen their portfolios through collaborations with local players or distribution partners. All such recent developments related to companies manufacturing psoriasis drugs have been tracked by the team at Persistence Market Research, which are available in the full report.
Key companies operating in the psoriasis drugs market include Janssen Biotech Inc, Novartis International Ltd., Amgen Inc, Pfizer Inc., Takeda Pharmaceutical Company Ltd. Merck & Co, Inc., Abb Vie Inc., Eli Lilly and Company, Boehringer Ingelheim GmbH, and Sun Pharmaceutical Industries Ltd.
What Does the Report Cover?
Persistence Market Research offers a unique perspective and actionable insights on the psoriasis drugs market in its latest study, presenting historical demand assessment of 2016 - 2021 and projections for 2022 - 2031.
The research study is based on the product (topical, oral, and injectable), drug class (interleukin inhibitors, corticosteroids, anti-inflammatory, and tumor necrosis factor inhibitor), distribution channel (hospital pharmacies, retail pharmacies, and e-Commerce), and indication (guttate psoriasis, inverse psoriasis, pustular psoriasis, erythrodermic psoriasis, and plaque psoriasis), across seven key regions of the world.
Request Customization @ https://www.persistencemarketresearch.com/request-customization/25102
Key Questions Answered in This Report.
What are the Roadblocks for Psoriasis Drugs Market Suppliers?
What are the Key Opportunities for Psoriasis Drugs Market Manufacturers?
How is Focus on Safety Influencing Psoriasis Drugs Market Demand?
What is the Regulatory Impact on Global Sales of Psoriasis Drugs Market?
Which Region Offers the Largest Opportunity for Sales of Psoriasis Drugs Market?
Where Does the U.S. Stand in the Market for Psoriasis Drugs Market?
What Is the Outlook for Psoriasis Drugs Market Manufacturers in China?
Why is Germany a Lucrative Market for Psoriasis Drugs Market Manufacturers?
Why Will Belgium Outpace Other European Markets for Psoriasis Drugs Market?
Why is There High Demand for Tires in Psoriasis Drugs Market?
Why are Sales of Psoriasis Drugs Market Surging?
For More Premium Insights, Check out the Link:
Functional Brain Imaging Systems Market - https://www.prnewswire.com/news-releases/functional-brain-imaging-systems-market-is-set-to-experience-a-significant-6-3-cagr-from-2021-to-2031---persistence-market-research-301484724.html
Mri Systems Market - https://www.prnewswire.com/news-releases/mri-systems-market-is-expected-to-register-a-cagr-of-6-5-over-the-forecast-period-2021-2031---persistence-market-research-301484669.html
Media Contact:
Persistence Market Research
305 Broadway,7th Floor New York City, NY 10007 United States
Call +1-646-568-7751
Call +1 800-961-0353
sales@persistencemarketresearch.com
About Us
Persistence Market Research is a U.S.-based full-service market intelligence firm specializing in syndicated research, custom research, and consulting services. Persistence Market Research boasts market research expertise across the Healthcare, Chemicals and Materials, Technology and Media, Energy and Mining, Food and Beverages, Semiconductor and Electronics, Consumer Goods, and Shipping and Transportation industries. The company draws from its multi-disciplinary capabilities and high-pedigree team of analysts to share data that precisely corresponds to clients' business needs.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Psoriasis Drugs Market is predicted to progress at a CAGR of 6.5% to reach US$ 21.48 Bn by 2031 here
News-ID: 2951899 • Views: …
More Releases from Persistence Market Research
Fabric Inspection Machine Market Growth Fueled by Textile Industry Expansion and …
Market Overview
The fabric inspection machine market has emerged as a crucial segment of the global textile and apparel industry, playing a vital role in ensuring consistent quality, minimizing defects, and enhancing operational efficiency. These machines are designed to detect weaving faults, knitting defects, color variation, and other quality-related issues before fabrics move to downstream processes. With the textile and apparel industry expanding rapidly across both developed and emerging economies, the…
Air Compressor Market Forecast, Rising Demand Across Manufacturing and Construct …
Market Overview
The global air compressor market has evolved into a cornerstone of modern industrial operations, offering indispensable solutions across sectors such as manufacturing, oil & gas, power generation, construction, healthcare, and automotive. Air compressors convert power into potential energy stored in compressed air, which is later used for a wide range of mechanical tasks. The growing demand for energy-efficient systems, combined with the need for reliable compressed air solutions in…
Computer Numerical Control (CNC) Machines Market Forecast, Technological Advance …
Market Overview
The global Computer Numerical Control (CNC) machines market is witnessing robust growth as industries increasingly adopt advanced manufacturing technologies to boost precision, speed, and productivity. In 2023, the market was valued at US$6.2 billion and is forecast to expand at a CAGR of 9.5%, reaching US$11.7 billion by 2030. CNC machines, which automate control of machining tools through computer programming, have become an indispensable part of sectors such as…
Millimeter Wave Body Scanner Market to Witness Strong Demand Across Airports & P …
Market Overview
The millimeter wave body scanner market has emerged as a critical segment within global security technologies, particularly in high-risk environments such as airports, government buildings, and public event venues. These scanners utilize non-ionizing millimeter wave technology to detect concealed objects on a person's body without physical contact, delivering both enhanced accuracy and safety compared to older technologies like X-ray scanners. The increasing need for advanced threat detection systems, coupled…
More Releases for Psoriasis
Psoriasis Vulgaris Market
Introduction
Psoriasis vulgaris, also known as plaque psoriasis, is the most common form of psoriasis, accounting for nearly 80-90% of all cases. It is a chronic autoimmune condition marked by red, scaly plaques that can cause significant physical discomfort and emotional distress. Affecting millions worldwide, psoriasis vulgaris is increasingly recognized as both a dermatological and systemic disease due to its association with arthritis, cardiovascular disease, and metabolic syndrome.
The global psoriasis vulgaris…
Major Growth Driver Identified in 2025 Psoriasis Market: Prevalence Of Psoriasis …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Psoriasis Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
In recent times, the size of the psoriasis market has experienced a significant increase. It is projected to escalate from $26.56 billion in 2024 to $29.5 billion in 2025, reflecting a compound annual growth rate (CAGR)…
Prevalence Of Psoriasis Driving Market Growth: Key Factor Driving The Growth In …
The Psoriasis Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Expected Psoriasis Market Size During the Forecast Period?
The psoriasis market has seen rapid growth in recent years. It will increase from $26.56 billion in 2024 to $29.5 billion in 2025, at a…
Plaque Psoriasis to Hold 85% Share of Psoriasis Drugs Market through 2031
Psoriasis is a chronic inflammatory skin disease that occurs due to genetic disposition and environmental factors. Psoriasis is a systemic disease associated with psychological, metabolic, arthritic, and cardiovascular comorbidities. On an average, psoriasis affects around 2 - 3% of the population globally.
Plaque psoriasis, being the number one and most common indication, held nearly 85% share of the US$ 11.37 Bn psoriasis drugs market in 2021, with the market estimated to…
Psoriasis - Pipeline Review, H1 2017
ReportsWorldwide has announced the addition of a new report title Psoriasis - Pipeline Review, H1 2017 to its growing collection of premium market research reports.
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Psoriasis - Pipeline Review, H1 2017, provides an overview of the Psoriasis (Immunology) pipeline landscape.
Psoriasis is a chronic skin condition caused by an overactive immune system. Symptoms of the disease include shedding of cells, flared up…
Global Psoriasis Market with Focus on Plaque Psoriasis: Outlook to 2020
Psoriasis is a chronic inflammatory skin disease primarily causing scaling and inflammation of skin, characterized by sharply demarcated, scaly, red skin lesions most often on the elbows, knees, scalps, hands and feet. It occurs when the body’s immune system sends out faulty signals that speed up the growth cycle of skin cells. Psoriasis has been majorly classified into Plaque psoriasis, Guttate psoriasis, Inverse psoriasis, Pustular psoriasis and Erytherodermic psoriasis. It…
